Delivery Order SPE2DB22D1106-SPE2DB25FESF5
Award Date
6/6/25
Potential Completion Date
6/9/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,002.18 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024. The contract has an ultimate completion date of December 13, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,034.24, was awarded on May 25, 2022, with a completion date of May 26, 2022. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,152.54, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 7, 2025. The contract is not designated as a Set-Aside. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,017.45, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 21, 2024. The award was made on February 20, 2024, and there was no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The award, with a ceiling value of $1,400.60, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 6, 2025. This award is not designated as a...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a prescription medication, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order valued at $7,929.00 with an ultimate completion date of October 15, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,242.80, is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to the Defense Logistics Agency (DLA). The contract, awarded on September 16, 2021, has a ceiling value of $14,330.88 and an ultimate completion date of September 17, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and both companies are registered in the System for...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,943.70 firm fixed-price contract is for the delivery of 250 mcg/0.5 ml syringes of the medication Ovidrel, with a completion date of May 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,456.60, is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a medical product. The contract is not set aside and is awarded as part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a...